Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction
To assess prognostic factors affecting successful low-intensity extracorporeal shockwave therapy (Li-ESWT) treatment of erectile dysfunction (ED) in patients with vasculogenic ED and to report 30-month follow-up. This study was conducted upon 425 patients with vasculogenic ED. Assessment of ED was d...
Gespeichert in:
| Veröffentlicht in: | Urology (Ridgewood, N.J.) N.J.), 2021-03, Vol.149, p.133-139 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 139 |
|---|---|
| container_issue | |
| container_start_page | 133 |
| container_title | Urology (Ridgewood, N.J.) |
| container_volume | 149 |
| creator | Adeldaeim, Hussein M. Abouyoussif, Tamer Gebaly, Omar El Assem, Akram Wahab, Moataza M. Abdel Rashad, Hazem Sakr, Mostafa Zahran, Abdel Rahman |
| description | To assess prognostic factors affecting successful low-intensity extracorporeal shockwave therapy (Li-ESWT) treatment of erectile dysfunction (ED) in patients with vasculogenic ED and to report 30-month follow-up.
This study was conducted upon 425 patients with vasculogenic ED. Assessment of ED was done using Sexual Health Inventory for Men (SHIM) score. Patients were treated by Li-ESWT using PiezoWave2 (Richard Wolf) device. Successful Li-ESWT was defined as 6-month SHIM score of 22-25. Patients with successful treatment were followed for 30 months.
Mean Baseline SHIM scores for the total population studied was 11.8 with a range from 5 to 20. After 6 months from treatment, 220 (51.8%) patients reported satisfactory sexual intercourse. Age, diabetes, hypertension, smoking, obesity, hyperlipidemia, pretreatment SHIM score, and the duration of ED were all found to be significant factors affecting the success of Li-ESWT. At 30-month follow-up, 168 (76.3%) patients from those who responded to Li-ESWT still reported satisfactory sexual intercourse with a SHIM score of 22-25 without using PDE5i.
Li-ESWT is safe and effective treatment of ED with 30 months success in 39.5% of patients treated. Li-ESWT should be offered to patients with mild-to-moderate ED and not to those with severe ED. |
| doi_str_mv | 10.1016/j.urology.2020.12.019 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2473902714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429520315168</els_id><sourcerecordid>2473902714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-6b9c7c3f1a5167114ea98438906a46f1a85dc6c882cff30d25fde31d4f85cd193</originalsourceid><addsrcrecordid>eNqFkE9vEzEQxS0EomnhI4B85LLBf9be9QmhEmilSCA1iKPl2uPWYWMH2xvYb8-GBK6cZvTmzTzND6FXlCwpofLtdjnmNKSHackImzW2JFQ9QQsqWNcopcRTtCBEkaZlSlygy1K2hBApZfccXXDOO94RvkCHLzk9xFRqsPg2umBNTblgnzK-G62FUvw44HX62YRYIZZQJ7z6VbOxKe9TBjPgu8dkv-Nv5gB48wjZ7Ce8mQd1B7Hi5PEqg61hAPxhmo_FuU_xBXrmzVDg5bleoa8fV5vrm2b9-dPt9ft1Y7kUtZH3ynaWe2oElR2lLRjVt7xXRJpWznIvnJW275n1nhPHhHfAqWt9L6yjil-hN6e7-5x-jFCq3oViYRhMhDQWzdqOK8I62s5WcbLanErJ4PU-h53Jk6ZEH5HrrT4j10fkmjJN_kS8PkeM9ztw_7b-Mp4N704GmB89BMi62ADRggtHMtql8J-I330HmAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473902714</pqid></control><display><type>article</type><title>Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Adeldaeim, Hussein M. ; Abouyoussif, Tamer ; Gebaly, Omar El ; Assem, Akram ; Wahab, Moataza M. Abdel ; Rashad, Hazem ; Sakr, Mostafa ; Zahran, Abdel Rahman</creator><creatorcontrib>Adeldaeim, Hussein M. ; Abouyoussif, Tamer ; Gebaly, Omar El ; Assem, Akram ; Wahab, Moataza M. Abdel ; Rashad, Hazem ; Sakr, Mostafa ; Zahran, Abdel Rahman</creatorcontrib><description>To assess prognostic factors affecting successful low-intensity extracorporeal shockwave therapy (Li-ESWT) treatment of erectile dysfunction (ED) in patients with vasculogenic ED and to report 30-month follow-up.
This study was conducted upon 425 patients with vasculogenic ED. Assessment of ED was done using Sexual Health Inventory for Men (SHIM) score. Patients were treated by Li-ESWT using PiezoWave2 (Richard Wolf) device. Successful Li-ESWT was defined as 6-month SHIM score of 22-25. Patients with successful treatment were followed for 30 months.
Mean Baseline SHIM scores for the total population studied was 11.8 with a range from 5 to 20. After 6 months from treatment, 220 (51.8%) patients reported satisfactory sexual intercourse. Age, diabetes, hypertension, smoking, obesity, hyperlipidemia, pretreatment SHIM score, and the duration of ED were all found to be significant factors affecting the success of Li-ESWT. At 30-month follow-up, 168 (76.3%) patients from those who responded to Li-ESWT still reported satisfactory sexual intercourse with a SHIM score of 22-25 without using PDE5i.
Li-ESWT is safe and effective treatment of ED with 30 months success in 39.5% of patients treated. Li-ESWT should be offered to patients with mild-to-moderate ED and not to those with severe ED.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2020.12.019</identifier><identifier>PMID: 33373703</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Extracorporeal Shockwave Therapy - methods ; Extracorporeal Shockwave Therapy - statistics & numerical data ; Follow-Up Studies ; Humans ; Impotence, Vasculogenic - diagnosis ; Impotence, Vasculogenic - therapy ; Male ; Middle Aged ; Patient Satisfaction ; Patient Selection ; Penile Erection - radiation effects ; Prognosis ; Severity of Illness Index ; Treatment Outcome</subject><ispartof>Urology (Ridgewood, N.J.), 2021-03, Vol.149, p.133-139</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-6b9c7c3f1a5167114ea98438906a46f1a85dc6c882cff30d25fde31d4f85cd193</citedby><cites>FETCH-LOGICAL-c365t-6b9c7c3f1a5167114ea98438906a46f1a85dc6c882cff30d25fde31d4f85cd193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2020.12.019$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33373703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adeldaeim, Hussein M.</creatorcontrib><creatorcontrib>Abouyoussif, Tamer</creatorcontrib><creatorcontrib>Gebaly, Omar El</creatorcontrib><creatorcontrib>Assem, Akram</creatorcontrib><creatorcontrib>Wahab, Moataza M. Abdel</creatorcontrib><creatorcontrib>Rashad, Hazem</creatorcontrib><creatorcontrib>Sakr, Mostafa</creatorcontrib><creatorcontrib>Zahran, Abdel Rahman</creatorcontrib><title>Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>To assess prognostic factors affecting successful low-intensity extracorporeal shockwave therapy (Li-ESWT) treatment of erectile dysfunction (ED) in patients with vasculogenic ED and to report 30-month follow-up.
This study was conducted upon 425 patients with vasculogenic ED. Assessment of ED was done using Sexual Health Inventory for Men (SHIM) score. Patients were treated by Li-ESWT using PiezoWave2 (Richard Wolf) device. Successful Li-ESWT was defined as 6-month SHIM score of 22-25. Patients with successful treatment were followed for 30 months.
Mean Baseline SHIM scores for the total population studied was 11.8 with a range from 5 to 20. After 6 months from treatment, 220 (51.8%) patients reported satisfactory sexual intercourse. Age, diabetes, hypertension, smoking, obesity, hyperlipidemia, pretreatment SHIM score, and the duration of ED were all found to be significant factors affecting the success of Li-ESWT. At 30-month follow-up, 168 (76.3%) patients from those who responded to Li-ESWT still reported satisfactory sexual intercourse with a SHIM score of 22-25 without using PDE5i.
Li-ESWT is safe and effective treatment of ED with 30 months success in 39.5% of patients treated. Li-ESWT should be offered to patients with mild-to-moderate ED and not to those with severe ED.</description><subject>Adult</subject><subject>Aged</subject><subject>Extracorporeal Shockwave Therapy - methods</subject><subject>Extracorporeal Shockwave Therapy - statistics & numerical data</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Impotence, Vasculogenic - diagnosis</subject><subject>Impotence, Vasculogenic - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Satisfaction</subject><subject>Patient Selection</subject><subject>Penile Erection - radiation effects</subject><subject>Prognosis</subject><subject>Severity of Illness Index</subject><subject>Treatment Outcome</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9vEzEQxS0EomnhI4B85LLBf9be9QmhEmilSCA1iKPl2uPWYWMH2xvYb8-GBK6cZvTmzTzND6FXlCwpofLtdjnmNKSHackImzW2JFQ9QQsqWNcopcRTtCBEkaZlSlygy1K2hBApZfccXXDOO94RvkCHLzk9xFRqsPg2umBNTblgnzK-G62FUvw44HX62YRYIZZQJ7z6VbOxKe9TBjPgu8dkv-Nv5gB48wjZ7Ce8mQd1B7Hi5PEqg61hAPxhmo_FuU_xBXrmzVDg5bleoa8fV5vrm2b9-dPt9ft1Y7kUtZH3ynaWe2oElR2lLRjVt7xXRJpWznIvnJW275n1nhPHhHfAqWt9L6yjil-hN6e7-5x-jFCq3oViYRhMhDQWzdqOK8I62s5WcbLanErJ4PU-h53Jk6ZEH5HrrT4j10fkmjJN_kS8PkeM9ztw_7b-Mp4N704GmB89BMi62ADRggtHMtql8J-I330HmAw</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Adeldaeim, Hussein M.</creator><creator>Abouyoussif, Tamer</creator><creator>Gebaly, Omar El</creator><creator>Assem, Akram</creator><creator>Wahab, Moataza M. Abdel</creator><creator>Rashad, Hazem</creator><creator>Sakr, Mostafa</creator><creator>Zahran, Abdel Rahman</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction</title><author>Adeldaeim, Hussein M. ; Abouyoussif, Tamer ; Gebaly, Omar El ; Assem, Akram ; Wahab, Moataza M. Abdel ; Rashad, Hazem ; Sakr, Mostafa ; Zahran, Abdel Rahman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-6b9c7c3f1a5167114ea98438906a46f1a85dc6c882cff30d25fde31d4f85cd193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Extracorporeal Shockwave Therapy - methods</topic><topic>Extracorporeal Shockwave Therapy - statistics & numerical data</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Impotence, Vasculogenic - diagnosis</topic><topic>Impotence, Vasculogenic - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Satisfaction</topic><topic>Patient Selection</topic><topic>Penile Erection - radiation effects</topic><topic>Prognosis</topic><topic>Severity of Illness Index</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adeldaeim, Hussein M.</creatorcontrib><creatorcontrib>Abouyoussif, Tamer</creatorcontrib><creatorcontrib>Gebaly, Omar El</creatorcontrib><creatorcontrib>Assem, Akram</creatorcontrib><creatorcontrib>Wahab, Moataza M. Abdel</creatorcontrib><creatorcontrib>Rashad, Hazem</creatorcontrib><creatorcontrib>Sakr, Mostafa</creatorcontrib><creatorcontrib>Zahran, Abdel Rahman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adeldaeim, Hussein M.</au><au>Abouyoussif, Tamer</au><au>Gebaly, Omar El</au><au>Assem, Akram</au><au>Wahab, Moataza M. Abdel</au><au>Rashad, Hazem</au><au>Sakr, Mostafa</au><au>Zahran, Abdel Rahman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2021-03</date><risdate>2021</risdate><volume>149</volume><spage>133</spage><epage>139</epage><pages>133-139</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>To assess prognostic factors affecting successful low-intensity extracorporeal shockwave therapy (Li-ESWT) treatment of erectile dysfunction (ED) in patients with vasculogenic ED and to report 30-month follow-up.
This study was conducted upon 425 patients with vasculogenic ED. Assessment of ED was done using Sexual Health Inventory for Men (SHIM) score. Patients were treated by Li-ESWT using PiezoWave2 (Richard Wolf) device. Successful Li-ESWT was defined as 6-month SHIM score of 22-25. Patients with successful treatment were followed for 30 months.
Mean Baseline SHIM scores for the total population studied was 11.8 with a range from 5 to 20. After 6 months from treatment, 220 (51.8%) patients reported satisfactory sexual intercourse. Age, diabetes, hypertension, smoking, obesity, hyperlipidemia, pretreatment SHIM score, and the duration of ED were all found to be significant factors affecting the success of Li-ESWT. At 30-month follow-up, 168 (76.3%) patients from those who responded to Li-ESWT still reported satisfactory sexual intercourse with a SHIM score of 22-25 without using PDE5i.
Li-ESWT is safe and effective treatment of ED with 30 months success in 39.5% of patients treated. Li-ESWT should be offered to patients with mild-to-moderate ED and not to those with severe ED.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33373703</pmid><doi>10.1016/j.urology.2020.12.019</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-4295 |
| ispartof | Urology (Ridgewood, N.J.), 2021-03, Vol.149, p.133-139 |
| issn | 0090-4295 1527-9995 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2473902714 |
| source | MEDLINE; ScienceDirect Freedom Collection (Elsevier) |
| subjects | Adult Aged Extracorporeal Shockwave Therapy - methods Extracorporeal Shockwave Therapy - statistics & numerical data Follow-Up Studies Humans Impotence, Vasculogenic - diagnosis Impotence, Vasculogenic - therapy Male Middle Aged Patient Satisfaction Patient Selection Penile Erection - radiation effects Prognosis Severity of Illness Index Treatment Outcome |
| title | Prognostic Indicators for Successful Low-intensity Extracorporeal Shock Wave Therapy Treatment of Erectile Dysfunction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A38%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Indicators%20for%20Successful%20Low-intensity%20Extracorporeal%20Shock%20Wave%20Therapy%20Treatment%20of%20Erectile%20Dysfunction&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Adeldaeim,%20Hussein%20M.&rft.date=2021-03&rft.volume=149&rft.spage=133&rft.epage=139&rft.pages=133-139&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2020.12.019&rft_dat=%3Cproquest_cross%3E2473902714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473902714&rft_id=info:pmid/33373703&rft_els_id=S0090429520315168&rfr_iscdi=true |